Vulvovaginal candidiasis (VVC) is an extremely common cause of vaginal symptoms in women. Multiple antifungal products are available by either the oral or vaginal route, although no new drugs have become available for two decades. Given the therapeutic equivalence of the antimycotic agents and their routes of administration, the specific drug and formulation selected is entirely arbitrary in relation to final treatment outcome. Nevertheless, multiple factors affecting preference, both practitioner-dependent and patient-dependent, impact on selection of a specific drug and route of administration. © 2014 Sobel.
CITATION STYLE
Sobel, J. D. (2013, December 16). Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Preference and Adherence. https://doi.org/10.2147/PPA.S38984
Mendeley helps you to discover research relevant for your work.